Plexus (PLXS) Expected to Release Quarterly Earnings on Wednesday

Plexus (NASDAQ:PLXS) is expected to announce its Q3 2026 results after the market closes on Wednesday, July 29th. Analysts expect the company to post earnings of $2.10 per share and revenue of $1.2295 billion for the quarter. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Investors can find conference call details on the company’s upcoming Q3 2026 earning results page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 8:30 AM ET.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings data on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.18. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The firm had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.13 billion. During the same period last year, the company earned $1.66 earnings per share. The company’s revenue was up 18.7% on a year-over-year basis. On average, analysts expect Plexus to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Plexus Price Performance

PLXS opened at $253.38 on Tuesday. The company has a fifty day moving average price of $274.29 and a two-hundred day moving average price of $231.82. The firm has a market capitalization of $6.78 billion, a PE ratio of 37.04 and a beta of 0.88. Plexus has a 52 week low of $123.36 and a 52 week high of $307.06. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.54.

Analyst Upgrades and Downgrades

Several analysts recently commented on PLXS shares. Zacks Research raised Plexus from a “strong sell” rating to a “hold” rating in a research note on Monday, July 13th. Wall Street Zen upgraded Plexus from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Raymond James Financial restated an “outperform” rating and issued a $275.00 price target on shares of Plexus in a report on Thursday, April 30th. Needham & Company LLC raised their price target on Plexus from $285.00 to $310.00 and gave the stock a “buy” rating in a research report on Monday, June 1st. Finally, Weiss Ratings upgraded Plexus from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, July 6th. Five research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $246.67.

Insider Activity

In other news, insider Michael J. Running sold 510 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $272.17, for a total transaction of $138,806.70. Following the completion of the sale, the insider owned 665 shares in the company, valued at approximately $180,993.05. This trade represents a 43.40% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Victor (Pang Hau) Tan sold 3,000 shares of the company’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $271.23, for a total value of $813,690.00. Following the sale, the insider owned 10,457 shares of the company’s stock, valued at approximately $2,836,252.11. The trade was a 22.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 20,481 shares of company stock valued at $5,519,183 in the last 90 days. 1.78% of the stock is owned by company insiders.

Hedge Funds Weigh In On Plexus

Institutional investors and hedge funds have recently bought and sold shares of the company. Victory Capital Management Inc. increased its position in Plexus by 130.0% in the 4th quarter. Victory Capital Management Inc. now owns 349,057 shares of the technology company’s stock valued at $51,311,000 after acquiring an additional 197,283 shares during the period. MetLife Investment Management LLC lifted its holdings in shares of Plexus by 713.3% during the fourth quarter. MetLife Investment Management LLC now owns 126,971 shares of the technology company’s stock worth $18,665,000 after purchasing an additional 111,360 shares during the period. Balyasny Asset Management L.P. bought a new stake in shares of Plexus in the third quarter worth $12,509,000. Arrowstreet Capital Limited Partnership grew its stake in shares of Plexus by 965.0% in the third quarter. Arrowstreet Capital Limited Partnership now owns 80,890 shares of the technology company’s stock worth $11,704,000 after purchasing an additional 73,295 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its holdings in Plexus by 75.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 160,149 shares of the technology company’s stock valued at $23,542,000 after purchasing an additional 68,675 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.